← Eichor
Condition: Papillomavirus Vaccines Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Papillomavirus Vaccines

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Strengthening HPV Immunization Through EPI Leveraged Delivery
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07377656Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vac
Phase 4 · 1 location(s) · Xiamen Innovax Biotech Co., Ltd · NCT07668271PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Stories to Prevent (StoP) HPV Cancers
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT06808776"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06587243A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413Effect of Different HPV Education Methods on Vaccination Intention in Young Women
NA · 1 location(s) · Emel GÜÇLÜ CİHAN · NCT07420556Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
NA · 79 location(s) · Hospital Israelita Albert Einstein · NCT06513494Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Phase 2/Phase 3 · 2 location(s) · Western Institute for Veterans Research · NCT05625633Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women
Phase N/A · 2 location(s) · Mahidol University · NCT06220747The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea
NA · 2 location(s) · Cukurova University · NCT07248904PCOM2 - The Physician Communication Intervention, Version 2.0
NA · 2 location(s) · University of Colorado, Denver · NCT05336240Provider Recommendation and HPV Vaccination
NA · 1 location(s) · Kaiser Permanente · NCT05365048Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subject
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06223568A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
NA · 1 location(s) · University of Florida · NCT06535139Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
Phase 1/Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06007092PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Phase 2 · 3 location(s) · Precigen, Inc · NCT06157151Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07266857Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Intro
NA · 1 location(s) · University Medical Centre Ljubljana · NCT06995157The STOP-HPV Scale Up Study
NA · 1 location(s) · University of California, Los Angeles · NCT06831383Parent Education About Human Papillomavirus (HPV)
NA · 1 location(s) · KTO Karatay University · NCT07447245HPV Vaccine, Imiquimod, and Metformin Combination Trial
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT06686043
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.